Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch - 27/07/22
Doi : 10.1016/j.diabet.2021.101294
Coralie Amadou a, b, ⁎ 
: Conception or design of the work, Data collection, Data analysis and interpretation, Drafting the article, Sylvia Franc a, c, d : Critical revision of the article, Final approval of the version to be published., Erik Huneker e : Critical revision of the article, Final approval of the version to be published., Guillaume Charpentier a, c : Critical revision of the article, Final approval of the version to be published., Alfred Penfornis a, b : Conception or design of the work, Data collection, Data analysis and interpretation, Critical revision of the article, Final approval of the version to be published.
: Conception or design of the work, Data collection, Data analysis and interpretation, Drafting the article, Sylvia Franc a, c, d : Critical revision of the article, Final approval of the version to be published., Erik Huneker e : Critical revision of the article, Final approval of the version to be published., Guillaume Charpentier a, c : Critical revision of the article, Final approval of the version to be published., Alfred Penfornis a, b : Conception or design of the work, Data collection, Data analysis and interpretation, Critical revision of the article, Final approval of the version to be published. a Department of Diabetes and Endocrinologyt, Sud-Francilien Hospital, Paris-Saclay University, Corbeil-Essonnes, France
b Paris-Saclay University, France
c CERITD (Center for Study and Research for the Intensification of Diabetes Treatment), Bioparc-Génopole, Évry, France
d LBEPS, Univ Evry, IRBA, Université Paris Saclay, Evry 91025, France
e Diabeloop SA
⁎Corresponding author at: Department of Diabetes and Endocrinologyt, Sud-Francilien Hospital, Paris-Saclay University, Corbeil-Essonnes, France.Department of Diabetes and EndocrinologytSud-Francilien HospitalParis-Saclay UniversityCorbeil-EssonnesFrance
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
No abstract (brief report).
Le texte complet de cet article est disponible en PDF.Keywords : Closed-loop system, Corticosteroid, Type 1 diabetes
Abbreviations : T1DM, CGM, TIR, TAR
Plan
© 2021
Elsevier Masson SAS. Tous droits réservés.
Vol 48 - N° 4
Article 101294- juillet 2022 Retour au numéro
Article précédent
- Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study
- Anda-Petronela Radan, Mihaela-Madalina Fluri, Konstantinos Nirgianakis, Beatrice Mosimann, Bettina Schlatter, Luigi Raio, Daniel Surbek
- Healing of diabetic foot ulcers is independently associated with the use of angiotensin receptor blockers but not with those of diuretics and angiotensin conversion enzyme inhibitors
- Marion Lapray, Jean-Michel Petit, Coralie Fourmont, Alexia Rouland, Bruno Vergès, Benjamin Bouillet
Bienvenue sur EM-consulte, la référence des professionnels de santé.